Widad group reiterates plan to sell oral-based Covid-19 vaccine in M'sia
17 Dec 2020 / 21:35 H. Pix for representational purpose only. KUALA LUMPUR: Widad Group Bhd has clarified that the rationale for its memorandum of collaboration with Rinani Dynamic Sdn Bhd inked on Dec 15 is to distribute, market and sell oral-based Covid-19 vaccine named VXA-Cov2-1 in Malaysia. Rinani Dynamic is the local representative for Vaxart Inc, a US-based company that manufactures the vaccine and other products. VXA-CoV2-1 is a single-dose Covid-19 tablet vaccine that Vaxart Inc says can be distributed conveniently without the need for cold-chain storage and distribution. Widad Gr...